Elan Corporation Plc News

Elan was upgraded by Exane BNP Paribas to a "neutral" rating in a research note issued on Thursday.

Greece is once again driving activity on Wall Street this morning, as hopes rise that the beleaguered euro-zone member is one step closer to avoiding default.

"In 2011, Elan made substantial progress across all areas of the company," said Mr.

Based in Mountain View, California, ChemoCentryx scheduled a $60 million IPO with a market capitalization of $510 million at a price range mid-point of $15 for Wednesday, February 8, 2012.

Citigroup Inc. : In Brazil, Citigroup , and other financial institutions, came under attack by computer hackers, hampering their sites, reports the Wall Street Journal.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Citi today announced that its Global Transaction Services business, acting through Citibank N.A., has been appointed by Elan Corporation, plc , a leading biotechnology company headquartered in Ireland, as the successor depositary bank for itsA American Depositary Receipt program.

All signs point to emerging biotech company Rainbow Coral Corp. finding its feet in biotechnology at exactly the right time: The biotech industry is off to a great start in the early stages of 2012.

Elan Corporation, plc announced today that it will present at the Leerink Swann 2012 Global Healthcare Conference on Wednesday February 15, 2012 at 2.00 p.m. Eastern Standard Time and 7.00 p.m. Greenwich Mean Time.

Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets.

Biogen Idec Inc. is slated to announce its fourth quarter and fiscal 2011 results on January 31.

Cutting-edge stem cell research is producing new breakthroughs that could potentially revolutionize the treatment of currently incurable diseases from cancer to brain injuries to headaches.

Amgen and Micromet announced that the companies have entered into a definitive merger agreement under which Amgen will acquire Micromet, a biotechnology company founded in Germany with its research and development center in Munich and headquarters in Rockville, Md., for $11 per share in cash.

Posted in : Long Ideas , News , Short Ideas , Rumors , FDA , M&A , After-Hours Center , Movers , Tech , Media , Trading Ideas The Agreement : Illumina announced Thursday that its Board of Directors adopted a Rights Agreement, pursuant to which one preferred stock purchase right will be distributed as a dividend on each share of the Company's common ... (more)

Biogen, Inc. , and Elan Corporation PLC Release: ASCEND Study to Evaluate the Effectiveness of TYSABRIA as a Treatment for Secondary-Progressive Multiple Sclerosis WESTON, Mass.

Recently, Quest Diagnostics received market authorization for its STRATIFY JCV Antibody ELISA testing service from the US Food and Drug Administration .

Biogen Idec, Inc. , Elan Corporation PLC Win FDA Approval of Label Change for Tysabri WESTON, Mass.

The ISEQ dipped slightly this afternoon but still managed to stay above the 3,000 mark with Europe's markets higher amid hopes that a second credit crunch can be averted.

News came Friday that Biogen Idec, Inc. and partner Elan Corp. won FDA approval for a label change on its multiple-sclerosis drug Tysabri.

After a decade of drug safety crises where medicines have mostly either wound up yanked or close to it , today's news about the multiple sclerosis drug Tysabri is positively amazing.